tinidazole

Brand: Tindamax

Prototype: metronidazole
Drug Class: nitroimidazole antibiotic/antiprotozoal
Drug Family: antibiotic
Subclass: second-generation nitroimidazole
Organ Systems: infectious-diseasegastrointestinal

Mechanism of Action

Prodrug activated by intracellular nitroreductases under anaerobic conditions; reactive nitroradicals disrupt DNA helical structure and strand breakage; bactericidal against anaerobes and cidal/static for protozoa.

DNA (nitro group reduced to reactive radicals)

Indications

  • bacterial vaginosis
  • trichomoniasis
  • giardiasis
  • amebiasis (intestinal and amebic liver abscess)
  • H. pylori eradication (alternative)

Contraindications

  • nitroimidazole hypersensitivity
  • first trimester pregnancy
  • nursing (discontinue breastfeeding during and 3 days after therapy)

Adverse Effects

Common

  • metallic taste
  • nausea
  • GI upset
  • headache

Serious

  • seizures
  • peripheral neuropathy (with prolonged use)
  • disulfiram-like reaction with alcohol

Pharmacokinetics (ADME)

Absorption ~100% oral bioavailability
Distribution widely distributed including CSF; crosses placenta
Metabolism hepatic (CYP3A4)
Excretion renal (20–25%) and fecal
Half-life 12–14 hours
Onset rapid
Peak 1–3 hours
Duration once-daily dosing for most indications
Protein Binding 12%
Vd moderate

Drug Interactions

Drug / Agent Mechanism Severity
alcohol disulfiram-like reaction (flushing, vomiting, tachycardia); avoid during and 3 days after therapy major
warfarin CYP3A4 inhibition increases warfarin effect; enhanced INR major
lithium reduced lithium clearance; toxicity risk major

Nursing Considerations

  1. Instruct patient to absolutely avoid alcohol during therapy and for 3 days after the last dose; even small amounts can cause severe disulfiram-like reaction.
  2. Tinidazole has a longer half-life than metronidazole, enabling shorter treatment courses (single-dose or 2-day treatment for many indications).
  3. Administer with food to reduce GI side effects; a single 2-gram dose is often used for trichomoniasis and giardiasis.
  4. Assess for baseline neurological symptoms; peripheral neuropathy risk with prolonged use.

Clinical Pearls

  • Tinidazole's longer half-life enables single-dose or once-daily therapy for most indications, improving adherence compared to the multiple-daily-dose metronidazole regimens.
  • For trichomoniasis, both partners must be treated simultaneously regardless of symptoms to prevent ping-pong reinfection.

Safety Profile

Pregnancy avoid
Lactation avoid
Renal Adjustment Not required
Hepatic Adjustment Required
TDM Not required